KRASness and PIK3CAness in Patients with Advanced Colorectal Cancer: Outcome after Treatment with Early-Phase Trials with Targeted Pathway Inhibitors

PURPOSE: To evaluate clinicopathologic and molecular features of patients with metastatic colorectal cancer (mCRC) and their outcomes in early-phase trials using pathway-targeting agents. PATIENTS AND METHODS: We analyzed characteristics of 238 patients with mCRC referred to the phase 1 trials unit...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrido-Laguna, Ignacio, Hong, David S., Janku, Filip, Nguyen, Ly M., Falchook, Gerald S., Fu, Siqing, Wheler, Jenifer J., Luthra, Rajyalakshmi, Naing, Aung, Wang, Xuemei, Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364990/
https://www.ncbi.nlm.nih.gov/pubmed/22675430
http://dx.doi.org/10.1371/journal.pone.0038033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364990/
https://www.ncbi.nlm.nih.gov/pubmed/22675430
http://dx.doi.org/10.1371/journal.pone.0038033

Ejemplares similares